# Aspen Neuroscience, Inc. Common Stock (ASPE)

> Aspen Neuroscience, Inc. Common Stock (ASPE) trades at $13.08 (+0.31%) as of 7:44:40 AM EST on Nov 3, 2026. Market cap is $379.18M.

Canonical: https://massive.com/quote/aspe
Data as of: 2026-11-03T12:44:40.653Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$13.08** +0.04 (+0.31%)
As of 7:44:40 AM EST on Nov 3, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Aspen Neuroscience, Inc. Common Stock (ASPE) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -12.42% |
| 1W | — |
| 1M | — |
| YTD | -12.42% |
| 1Y | -12.42% |
| 52-wk range | $11.60 – $14.90 |

From daily closes through Nov 2, 2026.

## Key statistics

Today's trading snapshot for ASPE: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | — |
| Open | — |
| Prev close | $13.04 |
| Volume | 0 |
| Market cap | $379.18M |
| Shares out | 29.08M |

## Insider trading

[Aspen Neuroscience, Inc. Common Stock (ASPE) insider trading](https://massive.com/quote/aspe/insider-trading.md): open-market Form 4 buys and sells by Aspen Neuroscience, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Aspen Neuroscience, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 2, 2026 · Public offering
  “On November 2, 2026, the Company completed the IPO of 9,375,000 shares of the Company's common stock, par value $0.0001 per share, at a price to the public of $15.00 per share. The gross proceeds to the Company from the IPO were approximately $140.6 million, before deducting underwriting discounts and commissions and offering expenses payable by the Company.”

## Dividend history and stock splits

Aspen Neuroscience, Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-15 · Jan 13, 2009

## About Aspen Neuroscience, Inc. Common Stock

Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Listed | Oct 30, 2026 |

[Company website](https://www.aspenneuroscience.com)

## FAQ

### What is the Aspen Neuroscience, Inc. Common Stock (ASPE) stock price today?

Aspen Neuroscience, Inc. Common Stock (ASPE) is trading at $13.08 (+0.31% on the day) as of 7:44:40 AM EST on Nov 3, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Aspen Neuroscience, Inc. Common Stock?

Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need.

### What exchange is ASPE listed on?

Aspen Neuroscience, Inc. Common Stock (ASPE) trades on Nasdaq in USD.

## Live data

Prices here are 15-minute delayed. For real-time ASPE quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ASPE`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Aspen Neuroscience, Inc. Common Stock (ASPE) insider trading](https://massive.com/quote/aspe/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms